NRIX
Nurix Therapeutics Inc.
Latest News for NRIX
Nurix Therapeutics ( ($NRIX) ) has issued an announcement. On November 6, 2025, Nurix Therapeutics appointed Roger Dansey, M.D., to its board of di......
In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Nurix Therapeutics, with a price target of $28.00. Accordin......
Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Nurix Therapeutics today and set a price target of $28.00. The company’s shares open......
Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Nurix Therapeutics today and set a price target of $23.00. The company’s s......
Nurix Therapeutics, Inc. (($NRIX)) announced an update on their ongoing clinical study. Nurix Therapeutics, Inc. is conducting a Phase 1 clinical s......
Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NRIX | $16.76 | +9.3% | 2.33M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |